[ Price : $8.95]
FDA issues a guidance to help entities determine whether to register as a Section 503B outsourcing facility.[ Price : $8.95]
FDA accepts a La Jolla Pharmaceutical Co. IND for its novel formulation of hepcidin, indicated for treating iron overload.[ Price : $8.95]
In its latest batch of Warning Letters, FDA cites Alphatec Spine, R Thomas Marketing, and Royal Case Co.[ Price : $8.95]
Five drug companies raise questions about and suggest changes to an FDA draft guidance on assessment of male-mediated developmenta...[ Price : $8.95]
U.S. government prosecutors charge an online Canadian pharmacy with selling $78-million worth of unapproved and counterfeit drugs ...[ Price : $8.95]
Supernus Pharmaceuticals petitions FDA to require tighter bioequivalence parameters for ANDA applicants seeking to market generic ...[ Price : $8.95]
FDA approves a Taro Pharmaceutical Industries NDA for Keveyis (dichlorphenamide) 50 mg tablets for treating primary hyperkalemic a...[ Price : $8.95]
Federal Register Notice: Two FDA advisory committees will meet 9/10 to discuss Purdue Pharmas oxycodone immediate-release tablets....